Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Department of Neurology and Neuroscience, Cornell University, New York, NY 10065, USA.
Brain Behavior and Immunity (Impact Factor: 5.61). 03/2010; 24(6):1018-24. DOI: 10.1016/j.bbi.2010.03.002
Source: PubMed

ABSTRACT Some Lyme disease patients report debilitating chronic symptoms of pain, fatigue, and cognitive deficits despite recommended courses of antibiotic treatment. The mechanisms responsible for these symptoms, collectively referred to as post-Lyme disease syndrome (PLS) or chronic Lyme disease, remain unclear. We investigated the presence of immune system abnormalities in PLS by assessing the levels of antibodies to neural proteins in patients and controls. Serum samples from PLS patients, post-Lyme disease healthy individuals, patients with systemic lupus erythematosus, and normal healthy individuals were analyzed for anti-neural antibodies by immunoblotting and immunohistochemistry. Anti-neural antibody reactivity was found to be significantly higher in the PLS group than in the post-Lyme healthy (p<0.01) and normal healthy (p<0.01) groups. The observed heightened antibody reactivity in PLS patients could not be attributed solely to the presence of cross-reactive anti-borrelia antibodies, as the borrelial seronegative patients also exhibited elevated anti-neural antibody levels. Immunohistochemical analysis of PLS serum antibody activity demonstrated binding to cells in the central and peripheral nervous systems. The results provide evidence for the existence of a differential immune system response in PLS, offering new clues about the etiopathogenesis of the disease that may prove useful in devising more effective treatment strategies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The Lyme disease 'controversy' can be largely linked to the misconception that neurobehavioral effects of illness constitute evidence of nervous system infection. Appropriate differentiation between neuroborreliosis (nervous system B. burgdorferi infection) and Lyme encephalopathy (altered nervous system function in individuals with systemic but not nervous system infection) would lessen the controversy considerably, as the attribution of non-specific symptoms to supposed ongoing central nervous system infection is a major factor perpetuating the 'debate'. Epidemiologic considerations suggest that the entities referred to as "post-treatment Lyme disease" and "chronic Lyme disease" may not actually exist but rather reflect anchoring bias, linking common, non-specific symptoms to an antecedent medical event. On the other hand, there are data suggesting possible mechanisms by which post-treatment Lyme disease could occur.
    Clinical Infectious Diseases 02/2014; · 9.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. The causes of post-Lyme disease symptoms are unclear. Herein, we investigated whether specific immune responses correlated with such symptoms. Methods. The levels of 23 cytokines and chemokines, representative of innate and adaptive immune responses, were assessed in sera from 86 antibiotic-treated European patients with erythema migrans, 45 with post-Lyme symptoms and 41 without symptoms, who were evaluated prior to treatment and 2, 6, and 12 months thereafter. Results. At study entry, significant differences between groups were observed for the TH1-associated chemokines, CXCL9 and CXCL10, which were associated with negative Borrelia cultures, and the TH17-associated cytokine, IL-23, which was associated with positive cultures and the development of post-Lyme symptoms (P<0.02). Moreover, of the 41 patients with detectable IL-23 levels, 25 (61%) developed post-Lyme symptoms, and all 7 with IL-23 levels >230 ng/ml had such symptoms. Furthermore, antibody responses to the ECGF autoantigen were more common in patients with post-Lyme symptoms (P=0.07) and they correlated directly with IL-23 levels (P=0.02). Despite the presence of post-Lyme symptoms, all post-treatment culture results were negative, anti-borrelial antibody responses declined, and there were no objective signs of disseminated disease, suggesting that spirochetal eradication had occurred with treatment in all patients. Conclusions. High TH1-associated responses correlated with more effective immune-mediated spirochetal killing, whereas high TH17-associated immune responses, often accompanied by autoantibodies, correlated with post-Lyme symptoms, providing a new paradigm for the study of post-infectious symptoms in a subset of patients with Lyme disease.
    Clinical Infectious Diseases 11/2013; · 9.37 Impact Factor
  • Joint, bone, spine: revue du rhumatisme 02/2014; · 2.25 Impact Factor

Full-text (2 Sources)

Available from
Aug 5, 2014